Do autoantibodies shape cancer immunosurveillance?
Where this comes from
- Record sourced from PubMed, PMID 42492493.
- Also identified by DOI 10.1016/j.cell.2026.06.021.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Why cancer arises, progresses, or proves fatal in some people but not others remains largely unresolved. Antibody repertoires, including autoantibodies targeting immune pathways, may shape cancer immunosurveillance. Mapping antibody landscapes across cancer-free, at-risk, and cancer-affected individuals could clarify their roles in cancer susceptibility and disease outcome.
Medical subject headings
- Neoplasms
- Autoantibodies
- Immunologic Surveillance